URETER UROTHELIAL CARCINOMA

Clinical trials for URETER UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new URETER UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for URETER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immunotherapy combo shows promise for tough bladder cancers

Disease control Ongoing

This early-phase study tested two immunotherapy drugs, durvalumab and tremelimumab, given before surgery to patients with aggressive bladder cancer who cannot receive standard chemotherapy. The main goal was to check safety and side effects. Researchers also looked at how the dru…

Matched conditions: URETER UROTHELIAL CARCINOMA

Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 29, 2026 02:39 UTC

URETER UROTHELIAL CARCINOMA

Get alerted when new URETER UROTHELIAL CARCINOMA trials appear

Immunotherapy combo shows promise for tough bladder cancers